(HealthDay)—In a first, researchers have used genetically tweaked immune system cells to send a woman’s severe lupus into remission. The treatment—called CAR T-cell therapy—is already approved in the United States for fighting certain cases of blood cancer. It involves removing a patient’s own immune system T-cells, genetically altering them to target the cancer, then infusing